Publications
- [inserm-04075780] Oxytocin receptor agonist reduces perinatal brain damage by targeting microgliaby ano.nymous@ccsd.cnrs.fr.invalid (Jérôme Mairesse) on April 20, 2023
Abstract Prematurity and fetal growth restriction (FGR) are frequent conditions associated with adverse neurocognitive outcomes. We have previously identified early deregulation of genes controlling neuroinflammation as a putative mechanism linking FGR and abnormal trajectory of the developing […]
- [hal-04009875] Apnées obstructives et mixtes chez le souriceau DMSXL, modèle de la forme congénitale de la maladie de Steinertby ano.nymous@ccsd.cnrs.fr.invalid (Eléonore Sizun) on March 1, 2023
[...]
- [hal-03971379] Melatonin Levels in Preterm and Term Infants and Their Mothersby ano.nymous@ccsd.cnrs.fr.invalid (Valérie Biran) on February 3, 2023
The prevention of perinatal brain damage following preterm birth remains a public health priority. Melatonin has been shown to be a promising neuroprotectant in neonatal preclinical models of brain damage, but few studies have investigated melatonin secretion in newborns. We hypothesized that […]
- [hal-03971313] Cord blood procalcitonin level and early-onset sepsis in extremely preterm infantsby ano.nymous@ccsd.cnrs.fr.invalid (Alice Frerot) on February 3, 2023
Early-onset neonatal sepsis (EOS) is observed in 1.7% of extremely preterm infants, with high morbidity and mortality rate. Cord blood procalcitonin (PCT) is a sensitive marker of EOS in full-term newborns, but it has been rarely studied in premature infants. The diagnostic value of cord blood PCT […]
- [hal-03846658] A new ChEMBL dataset for the similarity-based target fishing engine FastTargetPred: Annotation of an exhaustive list of linear...by ano.nymous@ccsd.cnrs.fr.invalid (Shivalika Tanwar) on November 10, 2022
[...]
- [hal-03485655] Pharmacological treatment of attention-deficit/hyperactivity disorder in children and adolescents with epilepsyby ano.nymous@ccsd.cnrs.fr.invalid (S. Auvin) on December 20, 2021
[...]
- [hal-03451666] Surfen and oxalyl surfen decrease tau hyperphosphorylation and mitigate neuron deficits in vivo in a zebrafish model of tauopathyby ano.nymous@ccsd.cnrs.fr.invalid (Constantin Yanicostas) on November 26, 2021
Abstract Background Tauopathies comprise a family of neurodegenerative disorders including Alzheimer’s disease for which there is an urgent and unmet need for disease-modifying treatments. Tauopathies are characterized by pathological tau hyperphosphorylation, which has been shown to correlate […]
- [hal-03451644] Defective Excitatory/Inhibitory Synaptic Balance and Increased Neuron Apoptosis in a Zebrafish Model of Dravet Syndromeby ano.nymous@ccsd.cnrs.fr.invalid (Constantin Yanicostas) on November 26, 2021
Dravet syndrome is a type of severe childhood epilepsy that responds poorly to current anti-epileptic drugs. In recent years, zebrafish disease models with Scn1Lab sodium channel deficiency have been generated to seek novel anti-epileptic drug candidates, some of which are currently undergoing […]